In recent years COVID shots joined flu shots as an annual offering at most neighborhood pharmacies. But the current administration has thrown that into uncertainty

Headlines blared in May when U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. announced that the Centers for Disease Control and Prevention would stop recommending COVID-19 vaccinations for some people—namely healthy pregnant women and healthy children over 6 months old.

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.

Health officials are tracking a highly contagious new COVID-19 variant. This comes as confusion grows over vaccine recommendations moving forward.

COVID-19 is remains a public health concern five years after the start of the pandemic. What to know about vaccines, variants and more.

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce access to COVID-19 vaccines and restrict use to higher-risk populations. Here,

Conflicting recommendations from Trump administration health officials have left health experts, vaccine makers and insurers uncertain about what to advise.

Wisconsin health officials say RFK Jr.'s recent pullback of COVID-19 vaccine advice for kids and pregnant women isn’t based on new evidence.

Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in adults aged 65 and older, similar to already approved shots against the viruses in a late-stage trial.